Stopping GLP-1: What Happens When You Quit Semaglutide or Tirzepatide

Quick Answer

When you stop GLP-1 medication, appetite returns, and most patients regain significant weight within 12 months. The STEP 4 trial showed an average of 11.6% weight regain (about two-thirds of lost weight) in the year after stopping semaglutide. Hunger, cravings, and "food noise" typically return within weeks of the last dose.

The Evidence on Stopping GLP-1

The most direct data comes from the STEP 4 trial (Rubino et al., 2021):

Patients who continued semaglutide for 68 weeks: maintained 17.4% weight loss
Patients switched to placebo after 20 weeks: regained 6.9% of body weight (11.6% total weight change from baseline) over 48 weeks
The regain trajectory showed no sign of stopping at 48 weeks

The takeaway: weight loss achieved with GLP-1 is not maintained without the medication in most patients.

What Happens Physically When You Stop

Week 1–2

The medication's half-life means semaglutide takes approximately 5–7 weeks to fully clear from the body. In the first two weeks after the last dose, most patients notice:

Gradual return of appetite
Return of interest in previously satisfying foods
Possible return of "food noise" (intrusive thoughts about eating)

Week 3–6

As semaglutide clears and tirzepatide (half-life ~5 days) clears faster:

Hunger increases toward pre-medication levels
Portion sizes naturally increase
The sense of fullness that came easily begins to fade

Month 1–3

Most patients have returned to something near their pre-treatment appetite. Without the medication suppressing hunger, caloric intake increases toward baseline. Weight begins to return.

Month 3–12

In STEP 4, patients regained approximately 6.9% of starting body weight (two-thirds of what they'd lost) over this period. The regain trajectory was still rising at 48 weeks — suggesting continued regain beyond the trial period.

Why This Happens

Stopping GLP-1 doesn't cause weight gain — returning appetite causes it. The medication was suppressing hunger signals; when the medication leaves, those signals return. Without the biological suppression, the same biological drives that led to the original weight gain are active again.

Additionally, metabolic adaptation during weight loss (reduced basal metabolic rate) remains even after stopping, creating a context where eating at previous levels produces more weight gain relative to the now-lower body weight.

Can You Keep Weight Off After Stopping?

Some patients do maintain significant weight loss after stopping GLP-1 — but they're the minority. Factors that support better maintenance:

Developed sustainable habits during treatment: Patients who used the treatment period to establish consistent eating patterns, protein-focused diets, and regular exercise maintain better results.

Weight loss surgery history: Some post-bariatric patients have mechanical changes that support maintenance.

Reached a significantly lower weight plateau: Patients who lost 25%+ may maintain more even after regain.

Realistic expectation: expect 30–40% of lost weight to return within 12 months without continued medication.

How to Stop GLP-1 If You Need To

Tapering vs. Stopping Abruptly

GLP-1 medications don't require a medically necessary taper — the long half-life of semaglutide effectively creates a natural taper. However, some providers recommend stepping down doses (e.g., 2.4 mg → 1 mg → 0.5 mg over 2–3 months) to:

Allow gradual appetite adjustment
Slow the regain trajectory
Provide psychological transition

This isn't evidence-based but is reasonable practice.

If You Must Stop Temporarily

Reasons for temporary stops: surgery, pregnancy planning, cost gap, supply issues.

If stopping for less than 4 weeks: resume at the same dose when able. If stopping for 4+ weeks: your provider may restart at a lower dose to reacclimatize to the medication.

Plan for Regain

Stopping without a plan leads to uninstructed regain. If you know you're stopping:

Intensify resistance training to protect lean mass
Establish consistent meal structure before stopping
Have a target weight to resume medication at if regain occurs

Reasons People Stop GLP-1

Understanding the common reasons helps contextualize the decision:

Insurance loss or cost increase — most common real-world reason
Pregnancy planning — medication should be stopped; discuss timeline with provider
Reaching goal weight — often the intended stopping point, but regain still occurs
Side effects — intolerable GI symptoms in a small minority
Feeling "done" — misunderstanding the long-term nature of treatment

When Stopping Makes Sense

GLP-1 is not always a lifelong commitment. Stopping is reasonable if:

You've achieved significant weight loss and comorbidities have resolved
You've built robust habits and have a maintenance plan
Cost is prohibitive and you've exhausted access programs
You're planning pregnancy (recommended 2+ months before conception)

But enter any stop with realistic expectations: planning for some regain is more effective than being surprised by it.

Explore GLP-1 Programs with Long-Term Maintenance Support

Bottom Line

Stopping GLP-1 results in significant weight regain for most patients — on average, two-thirds of lost weight returns within 12 months. This reflects the biology of obesity as a chronic condition, not a failure of the medication. For patients who need to stop, having a transition plan (habits, exercise, realistic expectations) reduces regain. For most patients seeking to maintain results, GLP-1 treatment should be viewed as a long-term or indefinite commitment, similar to blood pressure medication.